Variceal Bleeding in Patients with Initation of Sofosbuvir and Ribavirin – Case Reports

Authors

  • Sadiq Memon Department of Gastroenterology, Asian Institute of Medical Sciences, Hyderabad, Pakistan.
  • Madiha Zaki Department of Gastroenterology, Indus Medical College Hospital, Tando Muhammad Khan, Pakistan.
  • Shahzad Ali Jiskani Department of Pathology, Indus Medical College Hospital, Tando Muhammad Khan, Pakistan.

Keywords:

Variceal bleeding, Sofosdbuvir, Ribavirin, Heptitis C, Nucleoside analogue, Antiviral

Abstract

Abstract: Sofosbuvir is an oral nucleoside analogue and potent inhibitor of the Hepatitis C virus (HCV) RNA polymerase that is used in combination with other antiviral agents to treat chronic Hepatitis C Nevertheless, and for unknown reasons, successful antiviral therapy of Hepatitis C with Sofosbuvir and other direct acting agents in patients with cirrhosis is occasionally complicated by hepatic decompensation. Here we describe 2 case report of upper gi bleed at initial days of treatment with Sofosbuvir and Ribavirin.

Downloads

Published

26.07.2021

How to Cite

1.
Memon S, Zaki M, Jiskani SA. Variceal Bleeding in Patients with Initation of Sofosbuvir and Ribavirin – Case Reports. Nat J Health Sci [Internet]. 2021 Jul. 26 [cited 2025 Jul. 13];5(4):175-6. Available from: https://ojs.njhsciences.com/index.php/njhs/article/view/185

Issue

Vol. 5 No. 4 (2020)

Section

Case Report

License

This is an Open Access journal distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.